NLS Pharmaceutics appoints Keith Harrison Dewedoff as interim CFO; stock slumps ~13%
- NLS Pharmaceutics (NASDAQ:NLSP) stock fell ~13% on Monday after the firm notifies that Keith Harrison Dewedoff has been appointed to the position of Interim Chief Financial Officer.
- NLS also announces that Chad Hellmann has resigned as CFO of the company and will remain with the company through May 31, 2023, to assist with the CFO transition.
- Mr. Dewedoff also serves as a CFO and Advisor for Danforth Advisors, LLC, an advisory firm focused on providing financial strategy to life sciences organizations.
- Most recently, Mr. Dewedoff served as CFO for Code Biotherapeutics, Inc., overseeing all accounting and finance functions, and advising on strategic financing activities.